text: OrexoTypePublicTraded asNasdaq Stockholm: ORXISINSE0000736415IndustryPharmaceuticalFounded1995 (1995)HeadquartersUppsala, SwedenArea servedWorldwideKey peopleNikolaj Sørensen(CEO)ProductsSee listRevenueIncrease SEK 429.4 million (2013)Net incomeDecrease SEK 154.9 million (2013)Number of employees108 (2013) WebsiteOrexo.comFootnotes / referencesEmployee and financial data as of 2014